August 18, 2011
Soy isoflavone tablets do not appear to be associated with a reduction in bone loss or menopausal symptoms in women within the first five years of menopause, according to a report in the August 8 issue of Archives of Internal Medicine.
The beginning stages of menopause are often accompanied by rapid bone loss, hot flashes, vaginal dryness and sleep disturbances among other symptoms, according to the article. “Estrogen therapy with or without progesterone prevents most of these changes. However, as a result of the Women’s Health Initiative findings suggesting that the overall risks outweigh the benefits, most menopausal women now decline estrogen therapy, increasingly seeking other alternatives,” wrote the authors. “Soy-derived products have been proposed to provide comparable benefits to estrogens, but without the risks.”
Silvina Levis, MD, of the Miami Veterans Affairs Healthcare System and Miller School of Medicine, University of Miami, and colleagues, conducted a randomized, controlled trial to determine the effectiveness of soy isoflavone tablets in preventing bone loss and other menopausal symptoms. Study participants received a soy isoflavone dose equivalent to approximately two times the highest intake through food sources in a typical Asian diet to ensure they received an effective dose. Women 45 to 60 years of age, within five years of menopause and with a bone mineral density T score (bone density compared with what is normally expected in a healthy young adult of the same sex) of -2.0 or higher in the lumbar spine or total hip were eligible for the study.
A total of 248 women were eligible for the study; 126 were randomized to the group receiving placebo tablets and 122 were randomized to the soy isoflavone group, who received 200mg of soy isoflavone tablets daily. During two years of follow-up, no significant differences were found between women in the soy isoflavone group and placebo group regarding changes in bone mineral density of the spine (-2 percent vs. -2.3 percent), the total hip (-1.2 percent vs. -1.4 percent) or the femoral neck (-2.2 percent vs. -2.1 percent), respectively.
Additionally, the number of menopausal symptoms was comparable between the two groups at baseline and the end of the study, except hot flashes. At the end of the study, 48.4 percent of women in the soy isoflavone group and 31.7 percent of women in the placebo group reported hot flashes. The authors also found that a higher number of women in the soy group reported constipation compared with women taking placebo (31.2 percent vs. 20.6 percent), but this was not statistically significant.
“Because of concerns regarding the risk of estrogens, a need exists for alternative interventions that could provide the beneficial effects of estrogens in bone and menopausal symptoms without the adverse effects on breast and cardiovascular health,” the authors concluded. However, “we found that our population of women in the first five years of menopause, on average, had low rates of bone loss, and that 200mg of soy isoflavone tablets taken once daily does not prevent bone loss or reduce bone turnover or menopausal symptoms.”
Bioforce USA (Ghent, NY) has announced that it has acquired the Bekunis® brand in the U.S. Bekunis has long included both the pleasant-tasting leaf and the instant tea form, and now this popular natural laxative is being offered in a convenient, easy-to-take tablet form as well.
“Unfortunately, many of us find that we need help from time to time with our digestive function,” said Pierce Sioussat, president of Bioforce USA. “A quick look at our store shelves shows that there are not many choices for those seeking laxative relief. And the conventional alternatives can be harsh and habit forming. We believe that Bekunis is the safe, natural choice for gentle relief. And with so many dosage forms available, there is an acceptable laxative solution for everyone. We are happy to have Bekunis in our family of brands because it offers our customers dependable, gentle relief for one of life’s most common problems.”
Bekunis is made from senna fruit extract and works in harmony with the body to relieve simple constipation.
For more information, visit www.bioforceusa.com.
MOM’s Organic Market, Maryland’s homegrown organic grocery company, is scheduled to complete its College Park store’s substantial remodeling and expansion project on August 19, 2011. The store is located at 9827 Rhode Island Ave. and will host a renovation celebration on August 19th, 20th and 21st to commemorate the store’s improved space and to thank its patrons and vendors for their patience during the remodeling process.
The College Park venue opened in August 2000 and was the second store launched by MOM’s. The store’s selection of 100 percent organic produce, organic and natural dairy items, bulk foods, local organic meats, raw foods, 100 percent sustainable seafood choices, pet products, gluten-free foods and environmentally friendly household products was well received by the neighborhood and, though the College Park store is the smallest of the company’s seven stores, it generates more revenue per square foot than any other location.
The long-awaited renovation will give the store 40 percent more shelf space with wider aisles and a greater selection of all natural and organic products. The newly remodeled store will uphold MOM’s mission to protect and restore the environment by using LED track lighting throughout the store and low VOC paint. Its entire line of energy efficient closed-door refrigerators and freezers will also use LED lights. The redesigned store will have skylights and an electric car charging station, and will use 100 percent wind power.
The Renovation Celebration will commence during regular store hours throughout the weekend. Customers will be given goody bags, have a chance to try local vendor demos, participate in kids activities, enter raffle drawings and try tasty food samples.
For more information, visit www.momsorganicmarket.com.
Lundberg Family Farms® (Richvale, CA) has launched a new initiative to help nurture, grow and redefine a new generation of organic family farmers. Raising Organic Family Farms is a multi-year program designed to inspire a new generation of organic family farmers and provide financial, education and mentoring support to aspiring agricultural entrepreneurs.
“Our heritage is firmly rooted in the practice of organic and sustainable farming,” said Grant Lundberg, CEO of Lundberg Family Farms. “Raising Organic Family Farms is our way of encouraging responsible land stewardship and [seeing that] sustainable agriculture remains a priority for emerging and aspiring farmers.”
By sharing the Lundberg family’s legacy of expertise and success, Raising Organic Family Farms hopes to advance the importance of organic farming methods that produce wholesome, healthful foods while improving and protecting the environment. “New farmers often need a boost to get their businesses to the next level,” said Lundberg. “Whether it’s a piece of equipment, advice from an expert, an opportunity to expand their networks or just a kernel of wisdom that brings a big idea to life, Raising Organic Family Farms and its partners will provide the support these farmers need to establish their own legacies in sustainable agriculture.”
Through October 31st, aspiring commercial organic family farmers can self-nominate or be nominated at www.raisingorganicfamilyfarms.com. Entrants must submit a 500-word essay, along with optional photos and/or video content in one of three categories:
• Seed money for equipment, supplies or repairs
• Education funding towards schooling or conference registration
• Mentorship with experts in business planning, marketing, retail, livestock management or crop planning
A judging panel, including representatives from Lundberg Family Farms, will choose recipients in each category. Judges will determine the amount to be awarded for each category based on need. Up to $50,000 total in grants and scholarships will be awarded.
Raising Organic Family Farms is open to commercial farmers of all ages and experience levels, including beginning or transitioning organic farmers, college students, organizations and influencers active in growing the organic farming movement.
Sabinsa Corporation (East Windsor, NJ) has been awarded damages for Creative Compound’s (Scott City, MO) ForsLean® trademark infringement by the U.S. District Court of New Jersey. Creative Compounds was ordered to disgorge its profit of $139,388.40 from their sales of the infringing product and to pay those disgorged profits to Sabinsa.
On January 10, 2011, the U.S. Supreme Court denied Creative Compounds’ request to review the July 2010 decision of the Third Circuit Court in Sabinsa’s favor. The Third Circuit ruled that Creative Compounds infringed Sabinsa’s Forslean trademark because Creative Compounds created a likelihood of confusion between ForsLean and Creative Compounds’ Forsthin, both of which refer to Coleus forskohlii extract.
“This battle has taken a very long time to resolve, but we were confident that the courts would indeed confirm our ownership of this trademark and the similarity of the infringing company’s mark,” said Dr. Muhammed Majeed, Sabinsa founder. “We will always stand firmly behind our intellectual property to protect our investment and that of our customers.”
For more information, visit www.sabinsa.com.
Metabolic Technologies, Inc. (MTI, Ames, IA) and TSI Health Sciences (Missoula, MT) are combining their efforts to bring more innovative proprietary products to the marketplace. MTI is a successful research-driven company that develops credible, safe and effective nutritional products, and TSI Health Sciences has evolved throughout the last decade to excel in superior manufacturing processes and assurances and become a leading developer and producer of nutraceutical, food and pharmaceutical products sold in over 30 countries.
“The strategic partnership between MTI and TSI allows both parties to develop and commercialize products with shared resources, talent and vision, leading to greater long-term business value for both companies, as well as bringing a vast range of new, innovative ingredients to the marketplace faster and more effectively,” said Larry Kolb, TSI Health Sciences U.S. operations president.
“The goals for MTI and TSI are to collaborate and create clinically tested and proven ingredients protected by manufacturing expertise, know how or process patents, composition and use patents, brands and trademarks,” said Shawn Baier, COO for MTI.